Epstein-barr Virus Related Malignant Neoplasms

Top drugs studied for this disease

CLINICAL_TRIALS trial_result · 2026-04-21
Clinical Trial Update: BZLF1 Peptide Vaccine (OSU-2131) With QS-21 for the Prevention of Epstein-Barr Virus Related Cancer in Patients Awaiting Solid Organ Transplants [Phase 1]
Phase 1 trial of the BZLF1 peptide vaccine OSU-2131 with QS-21 to prevent Epstein-Barr virus–related cancers in patients awaiting solid orga…